Cardiol Therapeutics Inc. (TSX:CRDL)
Canada flag Canada · Delayed Price · Currency is CAD
1.920
+0.050 (2.67%)
Jun 6, 2025, 3:59 PM EDT

Cardiol Therapeutics Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
159151724414291
Upgrade
Market Cap Growth
-28.62%110.34%63.29%-69.05%55.49%-22.93%
Upgrade
Enterprise Value
13613531-2111375
Upgrade
Last Close Price
1.921.851.100.692.332.78
Upgrade
PS Ratio
----1803.25-
Upgrade
PB Ratio
9.026.112.540.841.866.88
Upgrade
P/TBV Ratio
9.026.112.560.851.877.13
Upgrade
EV/Sales Ratio
----1441.08-
Upgrade
Debt / Equity Ratio
0.010.010.010.000.000.01
Upgrade
Asset Turnover
----0.00-
Upgrade
Quick Ratio
3.054.414.256.127.295.66
Upgrade
Current Ratio
3.264.524.366.277.545.94
Upgrade
Return on Equity (ROE)
-190.11%-138.47%-69.93%-48.16%-70.69%-147.74%
Upgrade
Return on Assets (ROA)
-89.03%-73.43%-37.71%-34.47%-46.58%-82.38%
Upgrade
Return on Capital (ROIC)
-132.69%-94.44%-46.14%-40.17%-53.83%-91.42%
Upgrade
Earnings Yield
-22.55%-24.30%-39.19%-70.37%-22.28%-22.60%
Upgrade
FCF Yield
-15.96%-16.61%-35.17%-62.10%-16.58%-10.04%
Upgrade
Buyback Yield / Dilution
-15.55%-11.02%-3.13%-44.61%-44.77%-15.63%
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.